Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 654

1.

Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.

Allaire M, Cadranel JF, Nguyen TTN, Garioud A, Zougmore H, Heng R, Perignon C, Ollivier-Hourmand I, Dao T.

Clin Res Hepatol Gastroenterol. 2019 Nov 6. pii: S2210-7401(19)30224-4. doi: 10.1016/j.clinre.2019.10.003. [Epub ahead of print] Review.

PMID:
31706985
2.

CT assessment of peripheral traction bronchiolectasis: impact of minimal intensity projection.

de Margerie-Mellon C, Belin L, Boussouar S, Khafagy P, Debray MP, Levand K, Chabi ML, Khalil A, Benattia A, Israël-Biet D, Crestani B, Nunes H, Cadranel J, Grenier P, Valeyre D, Naccache JM, Brillet PY.

Eur Respir J. 2019 Oct 24. pii: 1901388. doi: 10.1183/13993003.01388-2019. [Epub ahead of print] No abstract available.

PMID:
31649065
3.

Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial.

Bennouna J, Girard N, Audigier-Valette C, le Thuaut A, Gervais R, Masson P, Marcq M, Molinier O, Cortot A, Debieuvre D, Cadranel J, Lena H, Moro-Sibilot D, Chouaid C, Mennecier B, Urban T, Sagan C, Perrier L, Barlesi F, Denis MG.

Clin Lung Cancer. 2019 Oct 1. pii: S1525-7304(19)30265-7. doi: 10.1016/j.cllc.2019.09.007. [Epub ahead of print]

PMID:
31648999
4.

Brief report : High MET overexpression does not predict the presence of MET exon 14 splice mutations in NSCLC : results from the IFCT Predict.amm study.

Baldacci S, Figeac M, Antoine M, Descarpentries C, Kherrouche Z, Jamme P, Copin MC, Tulasne D, Nanni I, Beau-Faller M, Melaabi S, Levallet G, Quoix E, Moro-Sibilot D, Friard S, Missy P, Barlesi F, Cadranel J, Cortot AB.

J Thorac Oncol. 2019 Oct 9. pii: S1556-0864(19)33524-5. doi: 10.1016/j.jtho.2019.09.196. [Epub ahead of print]

PMID:
31605799
5.

Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study.

Mehlman C, Cadranel J, Rousseau-Bussac G, Lacave R, Pujals A, Girard N, Callens C, Gounant V, Théou-Anton N, Friard S, Trédaniel J, Blons H, Dujon C, Duchemann B, Schischmanoff PO, Chinet T, Giroux Leprieur E.

Lung Cancer. 2019 Nov;137:149-156. doi: 10.1016/j.lungcan.2019.09.019. Epub 2019 Sep 28.

PMID:
31600593
6.

Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer.

Cadranel J, Canellas A, Matton L, Darrason M, Parrot A, Naccache JM, Lavolé A, Ruppert AM, Fallet V.

Eur Respir Rev. 2019 Oct 9;28(153). pii: 190058. doi: 10.1183/16000617.0058-2019. Print 2019 Sep 30. Review.

7.

Dramatic Radiation Recall Pneumonitis Induced by Osimertinib after Palliative Thoracic Radiotherapy for Lung Cancer.

Sanchis-Borja M, Parrot A, Sroussi D, Rivin Del Campo E, Fallet V, Cadranel J.

J Thorac Oncol. 2019 Oct;14(10):e224-e226. doi: 10.1016/j.jtho.2019.05.024. No abstract available.

PMID:
31558233
8.

[Lung transplantation for lepidic invasive adenocarcinoma: From a clinical question to an ethical consideration].

Créquit P, Cadranel J, Mal H, Grigoriu B, Berghmans T.

Rev Mal Respir. 2019 Oct;36(8):919-923. doi: 10.1016/j.rmr.2019.07.003. Epub 2019 Sep 11. French. No abstract available.

PMID:
31521430
9.

Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients.

Marques C, Carvelli J, Biard L, Faguer S, Provôt F, Matignon M, Boffa JJ, Plaisier E, Hertig A, Touzot M, Moranne O, Belenfant X, Annane D, Quéméneur T, Cadranel J, Izzedine H, Bréchot N, Cacoub P, Piedrafita A, Jourde-Chiche N, Saadoun D.

Front Immunol. 2019 Jul 18;10:1665. doi: 10.3389/fimmu.2019.01665. eCollection 2019.

10.

Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients.

Garioud A, Heng R, Amiot X, Rémy AJ, Ollivier-Hourmand I, Mokhtari C, Medmoun M, Renou C, Zougmoré H, Pulwermacher P, Lucidarme D, Rosa-Hézode I, Causse X, Arotcarena R, Zanditenas D, Halfon P, Pariente A, Cadranel JF; Association Nationale des Hépato-gastroentérologues des Hôpitaux Généraux (ANGH), France.

Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1270-1274. doi: 10.1097/MEG.0000000000001450.

PMID:
31219848
11.

Is chemotherapy rechallenge feasible in advanced-stage non-small-cell lung cancer?

Mignard X, Ruppert AM, Lavolé A, Vieira T, Rozensztajn N, Cadranel J, Wislez M.

Bull Cancer. 2019 Sep;106(9):725-733. doi: 10.1016/j.bulcan.2019.04.010. Epub 2019 Jun 13.

PMID:
31202557
12.

Effects of Age on Treatment of Chronic Hepatitis C with Direct Acting Antivirals.

Pariente A, Arpurt JP, Remy AJ, Rosa-Hezode I, Causse X, Heluwaert F, Macaigne G, Henrion J, Renou C, Schnee M, Salloum H, Hommel S, Pilette C, Arotcarena R, Barjonet G, Lison H, Bourhis F, Jouannaud V, Pauwels A, Le-Bricquir Y, Geagea E, Condat B, Ripault MP, Zanditenas D, de Montigny-Lenhardt S, Labadie H, Tissot B, Maringe E, Cadranel JF, Hagege H, Lesgourgues B; Association Nationale des Gastroenterologues des Hopitaux (ANGH).

Ann Hepatol. 2019 Jan - Feb;18(1):193-202. doi: 10.5604/01.3001.0012.7912.

13.

Ceritinib ALK T1151R Resistance Mutation in Lung Cancer With Initial Response to Brigatinib.

Mehlman C, Chaabane N, Lacave R, Kerrou K, Ruppert AM, Cadranel J, Fallet V.

J Thorac Oncol. 2019 May;14(5):e95-e96. doi: 10.1016/j.jtho.2018.12.036. No abstract available.

PMID:
31027750
14.

It's far better to be alone than to be in bad company.

Duruisseaux M, Cadranel J.

J Thorac Dis. 2019 Mar;11(3):649-651. doi: 10.21037/jtd.2019.02.65. No abstract available.

15.

[Transbronchial cryobiopsy in diffuse interstitial lung diseases].

Camuset J, Naccache JM, Dhalluin X, Febvre M, Wallyn F, Ouennoure O, Copin MC, Assouad J, Antoine M, Cadranel J, Fournier C.

Rev Mal Respir. 2019 Apr;36(4):455-460. doi: 10.1016/j.rmr.2018.10.618. Epub 2019 Apr 17. French.

PMID:
31005425
16.

Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).

Naccache JM, Montil M, Cadranel J, Cachanado M, Cottin V, Crestani B, Valeyre D, Wallaert B, Simon T, Nunes H.

BMC Pulm Med. 2019 Apr 11;19(1):75. doi: 10.1186/s12890-019-0830-x.

17.

Nivolumab-refractory patients with advanced non-small-cell lung cancer.

Costantini A, Fallet V, Corny J, Friard S, Chouaid C, Duchemann B, Giroux-Leprieur E, Taillade L, Doucet L, Brosseau S, Wislez M, Tredaniel J, Cadranel J.

Lung Cancer. 2019 Apr;130:128-134. doi: 10.1016/j.lungcan.2019.01.015. Epub 2019 Feb 14.

18.

Hepatitis C treatment with all-oral direct-acting antivirals: Effectiveness and tolerance in a multicenter, prospective, observational study from French general hospitals (APROVVIE, ANGH).

Pariente A, Arpurt JP, Rémy AJ, Rosa-Hézode I, Causse X, Heluwaert F, Macaigne G, Henrion J, Renou C, Schnee M, Salloum H, Hommel S, Pilette C, Arotcarena R, Barjonet G, Lison H, Bourhis F, Jouannaud V, Pauwels A, Le eaBricquir Y, Geagea E, Condat B, Ripault MP, Zanditenas D, de Montigny-Lenhardt S, Labadie H, Tissot B, Maringe E, Cadranel JF, Hagège H, Lesgourgues B; Association nationale des gastroentérologues des hôpitaux (ANGH).

Presse Med. 2019 Mar;48(3 Pt 1):e101-e110. doi: 10.1016/j.lpm.2018.06.019. Epub 2019 Mar 8.

PMID:
30853287
19.

Calpain 1 in bronchoalveolar lavage fluid is associated with poor prognosis in lepidic predominant pulmonary adenocarcinoma.

Ruppert AM, Baud L, Rabbe N, Perez J, Duruisseaux M, Vieira T, Antoine M, Cadranel J, Wislez M.

Bull Cancer. 2019 Mar;106(3):179-188. doi: 10.1016/j.bulcan.2018.11.014. Epub 2019 Jan 23.

PMID:
30683309
20.

Clinical Relevance of EGFR- or KRAS-mutated Subclones in Patients With Advanced Non-small-cell Lung Cancer Receiving Erlotinib in a French Prospective Cohort (IFCT ERMETIC2 Cohort - Part 2).

Beau-Faller M, Texier M, Blons H, Richard N, Escande F, Melaabi S, Lizard S, De Fraipont F, Longchampt E, Morin F, Zalcman G, Pignon JP, Cadranel J.

Clin Lung Cancer. 2019 May;20(3):222-230. doi: 10.1016/j.cllc.2018.12.012. Epub 2018 Dec 19.

PMID:
30679079
21.

Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung Cancer.

Reck M, Horn L, Novello S, Barlesi F, Albert I, Juhász E, Kowalski D, Robinet G, Cadranel J, Bidoli P, Chung J, Fritsch A, Drews U, Wagner A, Govindan R.

J Thorac Oncol. 2019 Apr;14(4):701-711. doi: 10.1016/j.jtho.2019.01.010. Epub 2019 Jan 21. Erratum in: J Thorac Oncol. 2019 Aug;14(8):1484.

PMID:
30677506
22.

Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo).

Halmos B, Tan EH, Soo RA, Cadranel J, Lee MK, Foucher P, Hsia TC, Hochmair M, Griesinger F, Hida T, Kim E, Melosky B, Märten A, Carcereny E.

Lung Cancer. 2019 Jan;127:103-111. doi: 10.1016/j.lungcan.2018.10.028. Epub 2018 Nov 2.

23.

[Mediastinitis after endobronchial ultrasound-guided transbronchial needle aspiration: Should we modify our practices?]

Febvre M, Souidi A, Fallet V, Sanchis Borja M, Izadifar A, Baud M, Pham S, Didier M, Cadranel J.

Rev Mal Respir. 2018 Dec;35(10):1063-1064. doi: 10.1016/j.rmr.2018.06.002. Epub 2018 Jul 7. French. No abstract available.

PMID:
30554592
24.

Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes.

Borie R, Bouvry D, Cottin V, Gauvain C, Cazes A, Debray MP, Cadranel J, Dieude P, Degot T, Dominique S, Gamez AS, Jaillet M, Juge PA, Londono-Vallejo A, Mailleux A, Mal H, Boileau C, Menard C, Nunes H, Prevot G, Quetant S, Revy P, Traclet J, Wemeau-Stervinou L, Wislez M, Kannengiesser C, Crestani B.

Eur Respir J. 2019 Feb 7;53(2). pii: 1800508. doi: 10.1183/13993003.00508-2018. Print 2019 Feb.

PMID:
30523160
25.

HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient's care behalf the CANCERVIH Group.

Gobert A, Spano JP, Cadranel J.

Med Oncol. 2018 Dec 5;36(1):13. doi: 10.1007/s12032-018-1224-2.

PMID:
30519774
26.

Chemoresistant pleomorphic rhabdomyosarcoma: whole exome sequencing reveals underlying cancer predisposition and therapeutic options.

Tlemsani C, Leroy K, Gimenez-Roqueplo AP, Mansuet-Lupo A, Pasmant E, Larousserie F, Boudou-Rouquette P, Vidaud M, Cadranel J, Blons H, Goldwasser F, Laurent-Puig P.

J Med Genet. 2018 Oct 23. pii: jmedgenet-2018-105594. doi: 10.1136/jmedgenet-2018-105594. [Epub ahead of print]

PMID:
30352869
27.

Management of severe hemoptysis.

Parrot A, Tavolaro S, Voiriot G, Canellas A, Assouad J, Cadranel J, Fartoukh M.

Expert Rev Respir Med. 2018 Oct;12(10):817-829. doi: 10.1080/17476348.2018.1507737. Epub 2018 Sep 10. Review.

PMID:
30198807
28.

New drugs in thoracic oncology: needs and knowledge - an online ERS Lung Cancer Assembly survey.

Berghmans T, Evison M, Blum TG, Peled N, Cadranel J.

ERJ Open Res. 2018 Sep 3;4(3). pii: 00040-2018. doi: 10.1183/23120541.00040-2018. eCollection 2018 Jul.

29.

c-MET Overexpression as a Poor Predictor of MET Amplifications or Exon 14 Mutations in Lung Sarcomatoid Carcinomas.

Mignard X, Ruppert AM, Antoine M, Vasseur J, Girard N, Mazières J, Moro-Sibilot D, Fallet V, Rabbe N, Thivolet-Bejui F, Rouquette I, Lantuejoul S, Cortot A, Saffroy R, Cadranel J, Lemoine A, Wislez M.

J Thorac Oncol. 2018 Dec;13(12):1962-1967. doi: 10.1016/j.jtho.2018.08.008. Epub 2018 Aug 24.

30.

Phase II study assessing the benefit of cisplatin re-introduction (stop-and-go strategy) in patients with advanced non-squamous non-small cell lung cancer: the IFCT-1102 BUCiL study (a Better Use of Cisplatin in Lung cancer).

Bennouna J, Barlesi F, Do P, Dumont P, Cadranel J, Debieuvre D, Hilgers W, Molinier O, Quoix E, Raimbourg J, Langlais A, Morin F, Souquet PJ.

ESMO Open. 2018 Jul 23;3(5):e000394. doi: 10.1136/esmoopen-2018-000394. eCollection 2018.

31.

Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer.

Touat M, Maisonobe T, Knauss S, Ben Hadj Salem O, Hervier B, Auré K, Szwebel TA, Kramkimel N, Lethrosne C, Bruch JF, Laly P, Cadranel J, Weiss N, Béhin A, Allenbach Y, Benveniste O, Lenglet T, Psimaras D, Stenzel W, Léonard-Louis S.

Neurology. 2018 Sep 4;91(10):e985-e994. doi: 10.1212/WNL.0000000000006124. Epub 2018 Aug 8. Erratum in: Neurology. 2019 Aug 6;93(6):280.

PMID:
30089619
32.

Infectious endocarditis in the case of cirrhosis: where do we stand?

Allaire M, Ollivier-Hourmand I, Garioud A, Heng R, Dao T, Cadranel JD.

Eur J Gastroenterol Hepatol. 2018 Dec;30(12):1406-1410. doi: 10.1097/MEG.0000000000001211. Review.

PMID:
30085963
33.

Lung cancer and interstitial lung disease: a literature review.

Naccache JM, Gibiot Q, Monnet I, Antoine M, Wislez M, Chouaid C, Cadranel J.

J Thorac Dis. 2018 Jun;10(6):3829-3844. doi: 10.21037/jtd.2018.05.75. Review.

34.

Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives.

Alastruey-Izquierdo A, Cadranel J, Flick H, Godet C, Hennequin C, Hoenigl M, Kosmidis C, Lange C, Munteanu O, Page I, Salzer HJF; on behalf of CPAnet.

Respiration. 2018;96(2):159-170. doi: 10.1159/000489474. Epub 2018 Jul 6. Review.

35.

Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times.

Loubière S, Barlesi F, Missy P, Morin F, Auquier P, Cadranel J.

Eur Respir J. 2018 Jun 21;51(6). pii: 1800844. doi: 10.1183/13993003.00844-2018. Print 2018 Jun. No abstract available.

PMID:
29929958
36.

[Peri-operative management of smoking].

Ruppert AM, Amrioui F, Fallet V, Cadranel J.

Rev Pneumol Clin. 2018 Jun;74(3):154-159. doi: 10.1016/j.pneumo.2018.04.007. Epub 2018 May 23. Review. French.

PMID:
29802008
37.

[Lungs and fungi: level of evidence and doubts].

Godet C, Cadranel J.

Rev Mal Respir. 2018 Apr;35(4):353-356. doi: 10.1016/j.rmr.2018.02.005. Epub 2018 May 10. French. No abstract available.

PMID:
29754842
38.

[Diagnostic uncertainty, working diagnosis and progress of recommendations for pulmonary fibrosis].

Cottin V, Crestani B, Cadranel J, Marchand-Adam S, Prévot G, Wallaert B, Valeyre D.

Rev Mal Respir. 2018 Apr;35(4):479-480. doi: 10.1016/j.rmr.2018.02.007. Epub 2018 May 10. French. No abstract available.

PMID:
29753638
39.

Severe liver failure rather than cirrhosis is associated with mortality in patients with infectious endocarditis: a retrospective case-control study.

Allaire M, Cadranel JD, Bureau C, Zerkly S, Thévenot T, Garioud A, Cacoub P, Macaigne G, Alric L, Jouannaud V, Lison H, Chagneau-Derrode C, Pariente A, Pe Combining Acute Accent Laquier ACGAS, Bourlie Combining Grave Accent Re M, Causse X, Nousbaum JB, Dumortier JCAAR, Louvet A, Rosa-He Combining Acute Accent Zode I, Ganne-Carrie Combining Acute Accent N, Chentouh R, Sfaxi A, Gournay JCAAR, Blasco-Perrin HCAALCGAN, Antonini T, Spahr L, Bronowicki JP, Silvain C, Di Martino V, Grange JD, Denis J, Dupont K, Iaria P, Ollivier-Hourmand I, Dao T; French association of gastroenterologist and hepatologist from primary hospital (ANGH).

Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1216-1223. doi: 10.1097/MEG.0000000000001155.

PMID:
29727379
40.

Rituximab for auto-immune alveolar proteinosis, a real life cohort study.

Soyez B, Borie R, Menard C, Cadranel J, Chavez L, Cottin V, Gomez E, Marchand-Adam S, Leroy S, Naccache JM, Nunes H, Reynaud-Gaubert M, Savale L, Tazi A, Wemeau-Stervinou L, Debray MP, Crestani B.

Respir Res. 2018 Apr 25;19(1):74. doi: 10.1186/s12931-018-0780-5.

41.

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer.

Costantini A, Corny J, Fallet V, Renet S, Friard S, Chouaid C, Duchemann B, Giroux-Leprieur E, Taillade L, Doucet L, Nguenang M, Jouveshomme S, Wislez M, Tredaniel J, Cadranel J.

ERJ Open Res. 2018 Apr 20;4(2). pii: 00120-2017. doi: 10.1183/23120541.00120-2017. eCollection 2018 Apr.

42.

Osimertinib in first-line treatment-is a comparison not proof?

Cadranel J.

Ann Transl Med. 2018 Feb;6(3):57. doi: 10.21037/atm.2017.12.13. No abstract available.

43.

Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer.

Costantini A, Cadranel J.

J Thorac Oncol. 2018 Apr;13(4):e55-e56. doi: 10.1016/j.jtho.2017.11.113. No abstract available.

44.

Effect of cannabis and tobacco on emphysema in patients with spontaneous pneumothorax.

Ruppert AM, Perrin J, Khalil A, Vieira T, Abou-Chedid D, Masmoudi H, Crequit P, Giol M, Cadranel J, Assouad J, Gounant V.

Diagn Interv Imaging. 2018 Jul - Aug;99(7-8):465-471. doi: 10.1016/j.diii.2018.01.017. Epub 2018 Mar 20.

45.

Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study.

Loubière S, Drezet A, Beau-Faller M, Moro-Sibilot D, Friard S, Wislez M, Blons H, Daniel C, Westeel V, Madroszyk A, Léna H, Merle P, Mazières J, Zalcman G, Lacave R, Antoine M, Morin F, Missy P, Barlesi F, Auquier P, Cadranel J; French Cooperative Thoracic Intergroup (IFCT).

Eur Respir J. 2018 Mar 15;51(3). pii: 1701467. doi: 10.1183/13993003.01467-2017. Print 2018 Mar.

46.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

47.

Efficacy of nebulized liposomal amphotericin B in the treatment of ABPA in an HIV/HBV co-infected man: Case report and literature review.

Garcia M, Le Moal G, Cadranel J, Roblot F, Godet C.

J Asthma. 2019 Jan;56(1):84-86. doi: 10.1080/02770903.2018.1429467. Epub 2018 Feb 16. No abstract available.

PMID:
29451812
48.

Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients.

Cadranel J, Cortot AB, Lena H, Mennecier B, Do P, Dansin E, Mazieres J, Chouaid C, Perol M, Barlesi F, Robinet G, Friard S, Thiberville L, Audigier-Valette C, Vergnenegre A, Westeel V, Slimane K, Buturuga A, Moro-Sibilot D, Besse B.

ERJ Open Res. 2018 Feb 13;4(1). pii: 00058-2017. doi: 10.1183/23120541.00058-2017. eCollection 2018 Jan.

49.

Safety and efficacy of pirfenidone in patients carrying telomerase complex mutation.

Justet A, Thabut G, Manali E, Molina Molina M, Kannengiesser C, Cadranel J, Cottin V, Gondouin A, Nunes H, Magois E, Tromeur C, Prevot G, Papiris S, Marchand-Adam S, Gamez AS, Reynaud-Gaubert M, Wemeau L, Crestani B, Borie R.

Eur Respir J. 2018 Mar 15;51(3). pii: 1701875. doi: 10.1183/13993003.01875-2017. Print 2018 Mar. No abstract available.

50.

Immunotherapy: a new standard of care in thoracic malignancies? A summary of the European Respiratory Society research seminar of the Thoracic Oncology Assembly.

Costantini A, Grynovska M, Lucibello F, Moisés J, Pagès F, Tsao MS, Shepherd FA, Bouchaab H, Garassino M, Aerts JGJV, Mazières J, Mondini M, Berghmans T, Meert AP, Cadranel J.

Eur Respir J. 2018 Feb 14;51(2). pii: 1702072. doi: 10.1183/13993003.02072-2017. Print 2018 Feb.

Supplemental Content

Loading ...
Support Center